{
    "600c9ebe-09f4-3df7-9dcc-5323c9016623": {
        "uuid": "600c9ebe-09f4-3df7-9dcc-5323c9016623",
        "title": "REFILE-U.S. to study whether longer Paxlovid course needed to combat reinfections",
        "publisher": "Reuters",
        "link": "https://finance.yahoo.com/news/u-study-whether-longer-paxlovid-162143570.html",
        "providerPublishTime": 1652890903,
        "type": "STORY"
    },
    "4fbe00e0-4289-3055-a50a-33178d183b3f": {
        "uuid": "4fbe00e0-4289-3055-a50a-33178d183b3f",
        "title": "Why Pfizer Looks Better Than Moderna as a Long-Term Buy",
        "publisher": "Motley Fool",
        "link": "https://finance.yahoo.com/m/4fbe00e0-4289-3055-a50a-33178d183b3f/why-pfizer-looks-better-than.html",
        "providerPublishTime": 1652889180,
        "type": "STORY"
    },
    "456625d4-a81b-3820-9e17-a09912b294f2": {
        "uuid": "456625d4-a81b-3820-9e17-a09912b294f2",
        "title": "Moderna (MRNA) Stock Rises 4%: What's Behind the Upside?",
        "publisher": "Zacks",
        "link": "https://finance.yahoo.com/news/moderna-mrna-stock-rises-4-141002671.html",
        "providerPublishTime": 1652883002,
        "type": "STORY"
    },
    "7070fcb3-33ee-3b26-8b54-f704a5443b0d": {
        "uuid": "7070fcb3-33ee-3b26-8b54-f704a5443b0d",
        "title": "Pfizer (PFE) Gets EUA for Use of Comirnaty Booster in Children",
        "publisher": "Zacks",
        "link": "https://finance.yahoo.com/news/pfizer-pfe-gets-eua-comirnaty-140702752.html",
        "providerPublishTime": 1652882822,
        "type": "STORY"
    },
    "b90b1ecc-a21f-36cd-bd78-9b73d99e6301": {
        "uuid": "b90b1ecc-a21f-36cd-bd78-9b73d99e6301",
        "title": "10 Best Vanguard Dividend Stocks with High Yields",
        "publisher": "Insider Monkey",
        "link": "https://finance.yahoo.com/news/10-best-vanguard-dividend-stocks-133955697.html",
        "providerPublishTime": 1652881195,
        "type": "STORY"
    },
    "8b3896c1-1b9b-33c9-9372-d3c0ca7b3095": {
        "uuid": "8b3896c1-1b9b-33c9-9372-d3c0ca7b3095",
        "title": "Is Ocugen Finally on the Way to Vaccine Revenue?",
        "publisher": "Motley Fool",
        "link": "https://finance.yahoo.com/m/8b3896c1-1b9b-33c9-9372-d3c0ca7b3095/is-ocugen-finally-on-the-way.html",
        "providerPublishTime": 1652869800,
        "type": "STORY"
    },
    "218edb7f-c700-38b3-8ff1-18623da6c4cc": {
        "uuid": "218edb7f-c700-38b3-8ff1-18623da6c4cc",
        "title": "From storage to transport, hurdles to getting COVID vaccine to N.Koreans",
        "publisher": "Reuters",
        "link": "https://finance.yahoo.com/news/storage-transport-hurdles-getting-covid-065644857.html",
        "providerPublishTime": 1652857004,
        "type": "STORY"
    },
    "f2ffc5de-9360-3289-a932-1d98c796caa2": {
        "uuid": "f2ffc5de-9360-3289-a932-1d98c796caa2",
        "title": "Pfizer Retakes A Key Line \u2014 And Drags BioNTech, Moderna With It",
        "publisher": "Investor's Business Daily",
        "link": "https://finance.yahoo.com/m/f2ffc5de-9360-3289-a932-1d98c796caa2/pfizer-retakes-a-key-line-%E2%80%94.html",
        "providerPublishTime": 1652817698,
        "type": "STORY"
    }
}